This week we look at an emerging funding source within biotechs, the hottest topics during the recent JP Morgan Healthcare Conference, a revolutionary app to automate insulin dosing, the struggle for Medicare reimbursement of obesity drugs, and the Food and Drug Administration’s final guidance on ... READ MORE >
Health care
5 things to know in life sciences: Week of Jan. 16, 2023
This week we look at growing pharmaceutical manufacturing investment, the potential for a biotech recovery in 2023, discussion about the future home of the JP Morgan Healthcare Conference, U.S. biopharma wins in the Chinese market, and the future of the Johnson & Johnson COVID-19 vaccine. Each week ... READ MORE >
5 things to know in life sciences: Week of Jan. 9, 2023
This week we look at proposed pricing increases for the Moderna COVID-19 vaccine, changes in the private equity landscape for biopharma and strategic announcements from Pfizer. We also highlight remarks from the Food and Drug Administration commissioner at the JP Morgan conference and major commitment in ... READ MORE >
Health care and cybersecurity insurance: The importance of understanding your organization’s coverage
Over the past decade, cybersecurity breaches in health care have become more pervasive and costly, and the nature of the attacks have changed. And while cyber insurance could be a way to protect organizations from these costly threats, there’s much to consider about this coverage. At one time ... READ MORE >
5 things to know in life sciences: Week of Dec. 19, 2022
It has been quite the year in life sciences as we try to define a new normal following the pandemic. While funding struggled, breakthroughs abounded. In addition, the Food and Drug Administration continued its work on drug pricing and clinical trial diversity. We can’t capture it all in one article, but ... READ MORE >
5 things to know in life sciences: Week of Dec. 12, 2022
This week we look at the doctors creating a personalized medicine to help a specific patient who had exhausted all other options. We also highlight options for using data to support Medicare drug pricing negotiation, large scale DNA sequencing projects in infants, and efforts to use genome sequencing to ... READ MORE >
5 things to know in life sciences: Week of Dec. 5, 2022
This week we look at the Food and Drug Administration’s vaccine activity related to RSV and COVID-19, mRNA opportunities to treat cancer, diversity in clinical trials, and a large in-licensing deal highlighting the industry’s recent move away from traditional funding sources. Each week we highlight ... READ MORE >
What do the latest job numbers say about the health care sector?
According to the latest nonfarm payroll jobs report published by the Bureau of Labor Statistics, health care added 44,700 jobs, which exceeded our estimate of 40,000. The overall economy added 263,000 jobs last month, a slight increase over October’s 261,000. These results also exceeded the consensus ... READ MORE >
5 things to know in life sciences: Week of Nov. 28, 2022
This week we look at mRNA technology that could be used in a universal flu vaccine, the rise in digital therapies despite a lack of insurance coverage, and another drug breaking the record for most expensive in the world. We also look at a new Centers for Disease Control and Prevention program to monitor ... READ MORE >
Reflections from 2022 and a look forward for the health care industry
As the calendar year comes to an end, it’s time for many organizations to reflect on challenges and issues from this year, as well as look to new efforts for the coming year. The following captures some key takeaways from 2022 and where health care leaders may want to focus on in 2023. What did we ... READ MORE >